Nephrogen is a biotech company developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.
Company Details
- Employees
- 5
- Founded
- -
- Address
- New York, New York 10027, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://nephrogenbiotech.com
- HQ
- New York, New York
Nephrogen Questions
Nephrogen's website is http://nephrogenbiotech.com
Nephrogen's LinkedIn profile is https://www.linkedin.com/company/nephrogen
Nephrogen has
5 employees.
View email and phone details for 5
employees at Nephrogen.
Nephrogen's industry is
Biotechnology Research
Nephrogen's top competitors are
Ankr Health,
Anthrogen (Yc S24),
Biolabs@nyulangone,
Orion Therapeutics, Inc.,
Nucleate New York,
Siphox Health,
Cleancard,
Cloverleaf Bio,
Dub Therapeutics,
Notable.
Nephrogen's categories are Biotechnology Research
Nephrogen's founding year is 2022
